Answers are grounded in this paper and cite their sources.
Complexes with bulky β-diketonate ligands demonstrate variable characteristics, indicating distinct structural properties.
In order to study the effect of bulky terminal substituents in the β-diketonate ligand on the structure and properties of volatile magnesium compounds, complexes with 2,2,6,6-tetramethylheptane-3,5-dione (HThd) and, for the first time, with 2-methoxy-2,6,6-trimethylheptane-3,5-dione (HZis) were obtained. The complexes [Mg(L)] (L = Thd (I), Zis (II)), the synthesis intermediates [Mg(HO)(L)] (L = Thd (III), Zis (IV)), and aqua derivative [Mg(HO)(Zis)] (V) were characterized by elemental analysis and IR spectroscopy. The structures of binuclear complexes and the synthesis by-product [Mg(Zis)(μ-OH)]Cl·5CHCl (VI) were established by X-ray diffraction (CCDC nos. 2424128 (Ia, a new polymorph), 2424130 (II), 2424129 (V), 2424126 (V·1/2CHCl), 2424127 (VI)). Both [Mg(L)] molecules are characterized by asymmetric environment of metal centers (Mg C.N. is 5, 6), but in I, three μ,κ:κ-ligands occupy bridging positions, while in II, two ligands have different coordinations (μ,κ:κ and μ,κ(O,O′):κ(O′,O)). The inclusion of water in II to give V is not accompanied by a considerable rearrangement of the structure, but C.N. of the unsaturated metal center changes from 5 to 6. It was shown by thermogravimetry that complex I is more volatile and low-melting than II.
No takes yet. Share an insight, caveat, or question.
E. A. Rikhter (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: